Glycobiology Market Is Projected To Grow Due To Increasing Investment In R&D By Research Institutes And Pharmaceutical & Biotechnology Companies Till 2025: Grand View Research, Inc.
The global glycomics/glycobiology market is expected to reach
USD 2.1 billion by 2025, according to a new report by Grand View Research, Inc.
Increasing investment in R&D by research institutes and pharmaceutical
& biotechnology companies has been a major factor driving market growth. In
addition, technological advancement has led to increased demand for advanced
glycomics products for drug discovery & development, diagnostics, and
oncology research.
Escalating popularity of
personalized medicines for the treatment of several severe chronic diseases and
genetic disorders is another major factor contributing toward the growth.
Personalized medicines involve the application of glycomics for the study of
structure and function of glycans that are attached to biomolecules. Glycans
play a crucial role in modulating various biological processes and their
assessment can help determine the susceptibility to diseases & response to
treatment. Thus, application of glycobiology products is expected to rise in
near future, owing to their high potential in personalized medicine.
Untapped opportunities in
developing regions, including Asia Pacific and Africa, are another major factor
supporting the growth of the glycomics market. Glycomics research is important
for comprehensive study of glycomes to understand the cellular signaling
pathways, cell functions, genetic structure, and physiological &
pathological aspects. Glycomics research has become more popular these days due
to its advantages over genomic/proteomic analysis that cannot be used to study
many pathological processes. Thus, the demand for advanced glycomics products
by researchers and healthcare professionals is expected to fuel the sector
growth.
U.S. glycomics/glycobiology
market, by product, 2014 - 2025 (USD million)
Browse full research report on
Glycobiology
Market
Further key findings from
the report suggest:
- Enzymes
segment is the fastest growing segment of the glycobiology market in 2016,
due to its huge application in research & diagnostics and repetitive
purchase of these products
- In the
application segment, drug discovery & development accounted for the
largest revenue share in 2016, owing to the growing focus on novel drug
development and demand for personalized medicines
- The academic
and research institutes dominated in terms of revenue in 2016, owing to
the large focus on glycobiology research and proteomics study
- The North
America glycobiology market is the leading regional sector and expected to
dominate the market during forecast period
- Existence of
large number of research laboratories, pharmaceutical companies, and
biotechnology companies in North America region is the major reason for
the high demand for glycobiology products in this region
- The Asia
Pacific glycobiology market is expected to grow at the highest growth rate
during the forecast period
- Some of the
major players include Danaher; ProZyme; Shimadzu Corporation; Agilent
Technologies; Bruker; Merck KGaA; Takara Bio, Inc.; New England Biolabs;
ThermoFisher Scientific, Inc.; and Waters Corporation
For
more information: http://www.grandviewresearch.com
Comments
Post a Comment